Search research articles
Contact Us
Filters
Showing results (341-350 of 377) with videos related to
Page
of 38
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
August 24, 1999
Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists
B R Martin, R Jefferson, R Winckler, et al.
Life Sciences
|
September 13, 2000
Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects
J L Wiley, M A Dewey, R G Jefferson, et al.
Journal of Neurochemistry
|
November 18, 2000
Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain
V Di Marzo, C S Breivogel, Q Tao, et al.
European Journal of Pharmacology
|
August 17, 1999
Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system
G Griffin, E J Wray, Q Tao, et al.
Pharmacotherapy
|
November 1, 1996
A pilot pharmacokinetic-pharmacodynamic study of benzodiazepine antagonism by flumazenil and aminophylline
M F Bonfiglio, L E Fisher-Katz, L M Saltis, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1993
Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities
D R Compton, K C Rice, B R De Costa, et al.
British Journal of Pharmacology
|
April 26, 2000
O-1057, a potent water-soluble cannabinoid receptor agonist with antinociceptive properties
R G Pertwee, T M Gibson, L A Stevenson, et al.
British Journal of Pharmacology
|
January 25, 2007
The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo
R G Pertwee, A Thomas, L A Stevenson, et al.
Drug and Alcohol Dependence
|
August 15, 2000
Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding
M M Aung, G Griffin, J W Huffman, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 12, 2003
Racial differences in bone turnover and calcium metabolism in adolescent females
R J Bryant, M E Wastney, B R Martin, et al.
Page
of 38
Search research articles
Search
Showing results (341-350 of 377) with videos related to
Sort By:
Page
of 38
The Journal of Pharmacology and Experimental Therapeutics
|
August 24, 1999
Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists
B R Martin, R Jefferson, R Winckler, et al.
Life Sciences
|
September 13, 2000
Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects
J L Wiley, M A Dewey, R G Jefferson, et al.
Journal of Neurochemistry
|
November 18, 2000
Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain
V Di Marzo, C S Breivogel, Q Tao, et al.
European Journal of Pharmacology
|
August 17, 1999
Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system
G Griffin, E J Wray, Q Tao, et al.
Pharmacotherapy
|
November 1, 1996
A pilot pharmacokinetic-pharmacodynamic study of benzodiazepine antagonism by flumazenil and aminophylline
M F Bonfiglio, L E Fisher-Katz, L M Saltis, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1993
Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities
D R Compton, K C Rice, B R De Costa, et al.
British Journal of Pharmacology
|
April 26, 2000
O-1057, a potent water-soluble cannabinoid receptor agonist with antinociceptive properties
R G Pertwee, T M Gibson, L A Stevenson, et al.
British Journal of Pharmacology
|
January 25, 2007
The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo
R G Pertwee, A Thomas, L A Stevenson, et al.
Drug and Alcohol Dependence
|
August 15, 2000
Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding
M M Aung, G Griffin, J W Huffman, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 12, 2003
Racial differences in bone turnover and calcium metabolism in adolescent females
R J Bryant, M E Wastney, B R Martin, et al.
Page
of 38